Valsartan Jubilant Tablet, film coated 80mg Malta - English - Medicines Authority

valsartan jubilant tablet, film coated 80mg

jubilant pharmaceuticals nv axxes business park, guldensporenpark 22 – block c, 9820 merelbeke, belgium - valsartan - film-coated tablet - valsartan 80 mg - agents acting on the renin-angiotensin system

Valsartan Jubilant Tablet, film coated 160mg Malta - English - Medicines Authority

valsartan jubilant tablet, film coated 160mg

jubilant pharmaceuticals nv axxes business park, guldensporenpark 22 – block c, 9820 merelbeke, belgium - valsartan - film-coated tablet - valsartan 160 mg - agents acting on the renin-angiotensin system

VALSARTAN -MEDO 160 MG Israel - English - Ministry of Health

valsartan -medo 160 mg

a.l. medi-market ltd. - valsartan - film coated tablets - valsartan 160 mg - valsartan - for treatment of hypertension. valsartan-medo is indicated for the treatment of heart failure (nyha class ii-iv) in patients who are intolerant of angiotensin converting enzyme inhibitors. in a controlled clinical trial valsartan-medo signicantly reduced hospitalisations for heart failure. there is no evidence that valsartan-medo provides added benefits when it is used with an adequate dose of an ace inhibitor. valsartan-medo is indicated to improve survival following myocardial infarction in clinically stable patients with signs symptoms or radiological evidence of left ventricular failure and /or with left ventricular systolic dysfunction.

VALSARTAN -MEDO 80 MG Israel - English - Ministry of Health

valsartan -medo 80 mg

a.l. medi-market ltd. - valsartan - film coated tablets - valsartan 80 mg - valsartan - for treatment of hypertension. valsartan-medo is indicated for the treatment of heart failure (nyha class ii-iv) in patients who are intolerant of angiotensin converting enzyme inhibitors. in a controlled clinical trial valsartan-medo signicantly reduced hospitalisations for heart failure. there is no evidence that valsartan-medo provides added benefits when it is used with an adequate dose of an ace inhibitor. valsartan-medo is indicated to improve survival following myocardial infarction in clinically stable patients with signs symptoms or radiological evidence of left ventricular failure and /or with left ventricular systolic dysfunction.

Valsartan Macleods 40 mg film-coated tablets Malta - English - Medicines Authority

valsartan macleods 40 mg film-coated tablets

macleods pharma españa, s.l.u. avenida diagonal, 468, 6°, puerta a, 08006, barcelona, spain - valsartan - film-coated tablet - valsartan 40 mg - agents acting on the renin-angiotensin system

Valsartan Macleods 80 mg film-coated tablets Malta - English - Medicines Authority

valsartan macleods 80 mg film-coated tablets

macleods pharma españa, s.l.u. avenida diagonal, 468, 6°, puerta a, 08006, barcelona, spain - valsartan - film-coated tablet - valsartan 80 mg - agents acting on the renin-angiotensin system

Valsartan Macleods 160 mg film-coated tablets Malta - English - Medicines Authority

valsartan macleods 160 mg film-coated tablets

macleods pharma españa, s.l.u. avenida diagonal, 468, 6°, puerta a, 08006, barcelona, spain - valsartan - film-coated tablet - valsartan 160 mg - agents acting on the renin-angiotensin system

Valsartan Macleods 320 mg film-coated tablets Malta - English - Medicines Authority

valsartan macleods 320 mg film-coated tablets

macleods pharma españa, s.l.u. avenida diagonal, 468, 6°, puerta a, 08006, barcelona, spain - valsartan - film-coated tablet - valsartan 320 mg - agents acting on the renin-angiotensin system

TEVA-VALSARTAN/HCTZ TABLET Canada - English - Health Canada

teva-valsartan/hctz tablet

teva canada limited - valsartan; hydrochlorothiazide - tablet - 80mg; 12.5mg - valsartan 80mg; hydrochlorothiazide 12.5mg - angiotensin ii receptor antagonists

TEVA-VALSARTAN/HCTZ TABLET Canada - English - Health Canada

teva-valsartan/hctz tablet

teva canada limited - valsartan; hydrochlorothiazide - tablet - 160mg; 12.5mg - valsartan 160mg; hydrochlorothiazide 12.5mg - angiotensin ii receptor antagonists